Abstract:Diamond-Blackfan anemia (DBA) is characterized by defective erythropoiesis, congenital anomalies and risk of malignancies. Ribosomal protein (RP) S19 is mutated in about 25% of patients and RPS24 in 2%. RPS19 deficiency impairs ribosomal biogenesis. It still remains unknown how impaired ribosome biogenesis and function lead to DBA. We found that RPS19 deficiency in zebrafish results in hematopoietic and developmental abnormalities resembling DBA. Our data suggest that the RPS19-deficient phenotype is mediated by upregulation of the p53 family genes. DeltaNp63 is BMP4 target and during gastrulation, required for specification of non-neural ectoderm. Its upregulation suppresses the development of neural structures and is likely to contribute to brain and craniofacial defects observed in RPS19 deficient zebrafish and DBA. In response to ribosomal stress from RPS19 deficiency, deltaNp63 expression is induced in erythroid progenitors suggesting a role for deltaNp63 in hematopoiesis. Similar to other vertebrates, zebrafish experience two waves of blood formation, primitive, producing mostly erythrocytes and macrophages and definitive producing all types of blood cells. Erythroid progenitors proliferate and differentiate into mature erythrocytes in the Intermediate Cell Mass (ICM), a region between the dorsal aorta and axial vein. We found that number of blood cells in the ICM was reduced in RPS19-deficient embryos and their differentiation was delayed. Morphologically, erythrocytes from morphants differed from wild-type cells. They varied in size and some cells retained a blast-like phenotype. The hemoglobin level was also decreased in morphants. The immature phenotype of RPS19-deficient erythroid cells and their inability to differentiate into mature erythrocytes may be explained by DNp63 induction. Importantly, downregulation of expression of both p53 and DNp63 can rescue the RPS19 deficient phenotype in zebrafish. Our findings suggest that suppression of p53 pathway might be beneficial for DBA patients with RPS19 mutations. Several drugs were reported to be effective in the treatment of DBA although the mechanism of their action is unknown. They include such dissimilar compounds as corticosteroids, cyclosporine A, and valproic acid. Metoxyclopramide was reported as effective by some authors but not others. We treated RPS19-deficient embryos with these drugs and found that dexamethasone, cyclosporine A, and valproic acid improve RPS19-deficient phenotype. We further found that treatment of embryos with dexamethasone and cyclosporine A influences p53 level. Metoxyclopramide was not effective in rescuing RPS19-deficient embryos and had no effect on p53 level. We next questioned if known compounds inhibiting p53 pathway can improve the phenotype and survival of RPS19-deficient zebrafish. Pifithrin m inhibits p53 binding to mitochondria by reducing its affinity to antiapoptotic proteins Bcl-xL and Bcl-2. It specifically suppresses the mitochondria branch of the p53 pathway but does not affect other p53 functions. Pifithrin has no effect of the p53 level in zebrafish embryos but was efficient in improving RPS19-deficient phenotype. These data suggest that suppression of p53 activity might be a mechanism of action of some drugs currently used for DBA treatment and open new directions for development of novel drugs.

Role of p53 family in birth defects: lessons from zebrafish.

p53 Isoform Δ113p53 in Zebrafish

p53 Isoform Delta113p53 in zebrafish.

P53 Isoform Delta 113p53 is A P53 Target Gene That Antagonizes P53 Apoptotic Activity Via Bclxl Activation in Zebrafish

Loss of Function of Def Selectively Up-Regulates Delta113p53 Expression to Arrest Expansion Growth of Digestive Organs in Zebrafish.

Structure Alignments of Zebrafish P53 Gene and Its Application in Ecotoxicology

Zebrafish reveal new roles for Fam83f in hatching and the DNA damage-mediated autophagic response

p53 family in development.

Zebrafish P53 Protein Enhances the Translation of Its Own Mrna in Response to UV Irradiation and CPT Treatment.

C1q-like Inhibits P53-Mediated Apoptosis and Controls Normal Hematopoiesis During Zebrafish Embryogenesis.

Loss of Zygotic NUP107 Protein Causes Missing of Pharyngeal Skeleton and Other Tissue Defects with Impaired Nuclear Pore Function in Zebrafish Embryos

Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.

Genome-Wide Survey And Developmental Expression Mapping Of Zebrafish Set Domain-Containing Genes

Imbalance of P53 Family Members As A New Target of Therapeutics for Treatment of Diamond Blackfan Anemia

Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.

A Naturally Occurring 4-Bp Deletion in the Intron 4 of P53 Creates a Spectrum of Novel P53 Isoforms with Anti-Apoptosis Function

Haploidy-linked cell proliferation defects limit larval growth in Zebrafish

Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development

Mice Deficient in the RNA-Binding Protein Zfp871 Are Prone to Early Death and Steatohepatitis in Part through the p53-Mdm2 Axis

Protein interaction between p53 and Δ113p53 is required for the anti-apoptotic function of Δ113p53.